TKNO FY 2020 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena

TKNOAlpha Teknova, Inc.

$135M

FY 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$31M+55.8% YoY

Gross Profit

$18M56.7% margin

Operating Income

$5M14.9% margin

Net Income

$4M11.4% margin

EPS (Diluted)

$0.16

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$300,000

Balance Sheet

Total Assets

$63M

Total Liabilities

$11M

Stockholders' Equity

$52M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$20M	+55.8%
Gross Profit	$18M	$9M	+107.1%
Operating Income	$5M	-$2M	+351.2%
Net Income	$4M	-$1M	+373.6%